IP Verse

Tapentadol For Preventing Chronification Of Pain - EP2694049

The patent EP2694049 was granted to Grnenthal on Oct 31, 2018. The application was originally filed on Apr 3, 2012 under application number EP12718064A. The patent is currently recorded with a legal status of "Revoked".

EP2694049

GRNENTHAL
Application Number
EP12718064A
Filing Date
Apr 3, 2012
Status
Revoked
Feb 2, 2024
Publication Date
Oct 31, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DEVELCO PHARMAJan 13, 2021GREINERWITHDRAWN
GENERICS UKJul 31, 2019ELKINGTON AND FIFEADMISSIBLE
HEXALJul 29, 2019KRAUS & LEDERER PARTGMBBWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0693475
DESCRIPTIONEP1985292
DESCRIPTIONUS2005058706
DESCRIPTIONUS4612008
DESCRIPTIONUS4765989
DESCRIPTIONUS4783337
INTERNATIONAL-SEARCH-REPORTEP1985292
INTERNATIONAL-SEARCH-REPORTWO2007128412
INTERNATIONAL-SEARCH-REPORTWO2009067703
OPPOSITIONEP1985292

Non-Patent Literature (NPL) Citations (50) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- BRENNAN TJ; VANDERMEULEN EP; GEBHART GF, "Characterization of a rat model of incisional pain", PAIN, (1996), vol. 64, pages 493 - 501
DESCRIPTION- E.A. SHIPTON, ANAESTH INTENSIVE CARE, (2011), vol. 39, pages 824 - 836
DESCRIPTION- EVANS W. E.; RELLING, M. V., "Pharmacogenomics: Translating Functional Genomics into Rational Therapies", SCIENCE, (1999), vol. 286, pages 487 - 491
DESCRIPTION- J.B. DAHL ET AL., CURR OPIN ANESTHESIOL, (2011), vol. 24, pages 331 - 338
DESCRIPTION- J.P. RATHMELL ET AL., ANESTHESIOLOGY, (2011), vol. 114, pages 1021 - 4
DESCRIPTION- L. DEYOUNG ET AL., MOLECULAR PAIN, (2008), vol. 4, no. 7, pages 1 - 12
DESCRIPTION- P. LAVAND'HOMME, CURR OPIN ANESTHESIOL, (2011), vol. 24, pages 545 - 550
DESCRIPTION- RAUSCHKOLB-LOEFFLER ET AL., ANNALS OF THE RHEUMATIC DISEASES, (2007), page 507
DESCRIPTION- T.J. BRENNAN, ANESTHESIOLOGY, (2010), vol. 112, pages 514 - 5
DESCRIPTION- TZSCHENTKE T. M. ET AL., "Tapentadol Hydrochloride", DRUGS OF THE FUTURE, (2006), vol. 31, pages 1053 - 1061
DESCRIPTION- W.A. MACRAE, BRITISH JOURNAL OF ANAESTHESIA, (2008), vol. 101, no. 1, pages 77 - 86
DESCRIPTION- W.A. MACRAE, BRITISH JOURNAL OF ANAETHESIA, (2008), vol. 101, no. 1, pages 77 - 86
EXAMINATION- -, "HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NUCYNTA   safely and effectively. See full prescribing information for NUCYNTA", (20100101), URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022304s003lbl.pdf, (20180608), XP055482355
EXAMINATION- LIANG DEYONG ET AL, "Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision", MOLECULAR PAIN, BIOMED CENTRAL, LONDON, GB, (20080222), vol. 4, no. 1, ISSN 1744-8069, page 7, XP021038581
EXAMINATION- MICHAEL OSSIPOV ET AL, "Descending pain modulation and chronification of pain", CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, (20150301), vol. 9, no. 1, pages 143 - 151, XP055391173
EXAMINATION- WILD JAMES E ET AL, "Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (201009), Database accession no. NLM20602712
EXAMINATION- WILD JAMES E ET AL, "Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain.", PAIN PRACTICE : THE OFFICIAL JOURNAL OF WORLD INSTITUTE OF PAIN, (201009), vol. 10, no. 5, ISSN 1533-2500, pages 416 - 427
EXAMINATION- KAI MCGREEVY ET AL, "Preventing chronic pain following acute pain: Risk factors, preventive strategies, and their efficacy", EUROPEAN JOURNAL OF PAIN SUPPLEMENTS, vol. 5, no. 2, doi:10.1016/J.EUJPS.2011.08.013, ISSN 1754-3207, (2011), pages 365 - 376, (20110810), XP028109432
EXAMINATION- PERGOLIZZI JOSEPH V ET AL, "Treating Acute Pain in Light of the Chronification of Pain", PAIN MANAGEMENT NURSING, (2012), vol. 15, no. 1, doi:10.1016/J.PMN.2012.07.004, ISSN 1524-9042, pages 380 - 390, XP028625563
EXAMINATION- W. A. Macrae, "Chronic post-surgical pain: 10 years on", BRITISH JOURNAL OF ANAESTHESIA., GB, (20080419), vol. 101, no. 1, doi:10.1093/bja/aen099, ISSN 0007-0912, pages 77 - 86, XP055391050
EXAMINATION- M. NIESTERS ET AL, "Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy", BRITISH JOURNAL OF ANAESTHESIA., GB, (20140408), vol. 113, no. 1, doi:10.1093/bja/aeu056, ISSN 0007-0912, pages 148 - 156, XP055391174
EXAMINATION- JOSEPH PERGOLIZZI ET AL, "The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment", CURRENT MEDICAL RESEARCH AND OPINION, GB, (20130703), vol. 29, no. 9, doi:10.1185/03007995.2013.810615, ISSN 0300-7995, pages 1127 - 1135, XP055391171
INTERNATIONAL-SEARCH-REPORT- ANONYMOUS, "Palexia® retard Retardtabletten (Tapentadol)", FACHINFORMATION ROTE LIST SERVICE, (201008), pages 1 - 5, URL: http://www.fachinfo.de/data/fi/jsearch?praep, (20110621), XP002643645 [X] 1-8,10-13 * chapter 1, chapter 2 and chapter 4.1 *
INTERNATIONAL-SEARCH-REPORT- RAUSCHKOLB-LOEFFLER C ET AL, "Efficacy and tolerability of tapentadol for relief of moderate-to-severe chronic pain due to osteoarthritis of the knee", ANNALS OF THE RHEUMATIC DISEASES, BRITISH MEDICAL ASSOCIATION, LONDON, GB, (20070616), vol. 66, no. Suppl. 2, ISSN 0003-4967, page 507, XP009101917 [X] 1-8,10-13 * abstract *
INTERNATIONAL-SEARCH-REPORT- TZSCHENTKE T M ET AL, "Tapentadol: mit zwei Mechanismen in einem Molekül wirksam gegen nozizeptive und neuropathische Schmerzen. Präklinischer Überblick = Tapentadol: with two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Preclinical overview", DER SCHMERZ ; ORGAN DER DEUTSCHEN GESELLSCHAFT ZUM STUDIUM DES SCHMERZES, DER ÖSTERREICHISCHEN SCHMERZGESELLSCHAFT UND DER DEUTSCHEN INTERDISZIPLINÄREN VEREINIGUNG FÜR SCHMERZTHERAPIE, SPRINGER, BERLIN, DE, vol. 25, no. 1, doi:10.1007/S00482-010-1004-1, ISSN 1432-2129, (20110201), pages 19 - 25, (20110123), XP009149538 [X] 1-8,11-13 * abstract * * page 21, column l, paragraph 1 *
OPPOSITION- Anonymous, "Palexia® retard Retardtabletten (Tapentadol)", Fachinformation Rote List Service, (20100000), pages 1 - 5, XP002643645
OPPOSITION- B.A. HASTIE et al., "Acute Pain Pathophysiology and Risk Factors for Chronification", Poster No. II-03 published at Benzon Symposium No. 57', (20101004), XP055781570
OPPOSITION- C. J. WOOLF et al., "Preemptive analgesia - treating postoperative pain by preventing the establishment of central sensitization", Anesth Analg, (19930000), vol. 77, no. 2, pages 362 - 79, XP055781684
OPPOSITION- C. VOSCOPOULOS et al., "When does acute pain become chronic?", Br J Anaesth., (20101200), pages i69 - 85, XP055781610
OPPOSITION- C. WOOLF, "Central Sensitization - Uncovering the Relation between Pain and Plasticity", the Amercian Society of Anesthesiologists, (20070000), vol. 106, pages 864 - 7, XP055781504
OPPOSITION- H. G. KRESS, "Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally-acting analgesics on the horizon?", European Journal of Pain, (20100000), vol. 14, pages 781 - 783, XP027224266
OPPOSITION- MICHAEL OSSIPOV et al., "Descending pain modulation and chronification of pain", Current Opinion In Supportive And Palliative Care, (20140601), vol. 8, no. 2, pages 143 - 151, XP055391173
OPPOSITION- OLIVER H. G. WILDER SMITH et al., "Postoperative Hyperalgesia", American Society of Anesthesiologists, (20200507), pages 601 - 607, XP055781563
OPPOSITION- "Part I", Opioids in Medicine. A Comprehensive Review on the Mode of Action and the Use of Analgesics in Different Clinical Pain States, Springer, (20080000), pages 1-13, 50 - 65, ISBN E. FREYE, XP055629841
OPPOSITION- PETERSEN-FELIX et al., "Neuroplasticity - An important factor in acute and chronic pain", Swiss medical weekly, (20020000), vol. 132, pages 273 - 8, XP055781500
OPPOSITION- RAUSCHKOLB-LOEFFLER C et al., "Efficacy and tolerability of tapentadol for relief of moderate- to-severe chronic pain due to osteoarthritis of the knee", Annals of the Rheumatic Diseases, (20070616), vol. 66, no. 2, page 507, XP009101917
OPPOSITION- "The MERCK Manual of diagnosis and therapy - 19th edition", (20110000), pages 1629 - 30, XP055781689
OPPOSITION- TZSCHENTKE T M et al., "Tapentadol: mit zwei Mechanismen in einem Molekul wirksam gegen nozizeptive und neuropathische Schmerzen. Praklinischer Uberblick, Der Schmerz", Der Schmerz: Organ Der Deutschen Gesellschaft Zum Studium Des Schmerzes, Der Osterreichischen Schmerzgesellschaft Und Der Deutschen Interdisziplinaren Vereinigung Fur Schmerztherapie, (20110201), vol. 25, no. 1, pages 19 - 25, XP009149538
OPPOSITION- T. J. BRENNAN et al., "Characterization of a rat model of incisional pain", Pain, (19960300), vol. 64, no. 3, pages 483 - 501, XP055628186
OPPOSITION- KAI MCGREEVY et al., "Preventing chronic pain following acute pain: Risk factors, preventive strategies, and their efficacy", European Journal of Pain Supplements, (20110000), vol. 5, no. 2, doi:10.1016/j.eujps.2011.08.013, pages 365 - 376, XP028109432
OPPOSITION- A. LATREMOLIERE et al., "Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity", J Pain, (20090000), vol. 10, no. 9, doi:10.1016/j.jpain.2009.06.012, pages 895 - 926, XP026494432
OPPOSITION- K. LEHMANN, "Recent Developments in Patient controlled Analgesia", Journal of Pain and Symptom Management, (20050500), vol. 29, no. 5S, doi:10.1016/j.jpainsymman.2005.01.005, pages 72 - 89, XP004903894
OPPOSITION- J. V. PERGOLIZZI et al., "Treating Acute Pain in Light of the Chronification of Pain", Pain Management Nursing, (20120111), vol. 15, no. 1, pages 380 - 390, XP028625563
OPPOSITION- PERGOLIZZI JOSEPH V et al., "Treating Acute Pain in Light of the Chronification of Pain", Pain Management Nursing, (20120000), vol. 15, no. 1, doi:10.1016/j.pmn.2012.07.004, pages 380 - 390, XP028625563
OPPOSITION- W.A. MACRAE, "Chronic Post-Surgical Pain: 10 years on", British Journal of Anaesthesia, (20080000), vol. 101, no. 1, doi:10.1093/bja/aen099, pages 77 - 86, XP055391050
OPPOSITION- M. NIESTERS et al., "Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy", British Journal of Anaesthesia, (20140000), vol. 113, no. 1, doi:10.1093/bja/aeu056, pages 148 - 56, XP055391174
OPPOSITION- M. NIESTERS et al., "Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy", British Journal of Anaesthesia, vol. 113, no. 1, doi:10.1093/bja/aeu056, pages 148 - 156, XP055391174
OPPOSITION- M. H. OSSIPOV et al., "Descending pain modulation and chronification of pain", Curr Opin Support Palliat Care, (20140600), vol. 8, no. 2, pages 143 - 151, XP055391172
OPPOSITION- JOSEPH PERGOLIZZI et al., "The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment", Current Medical Research and Opinion, vol. 29, no. 9, doi:10.1185/03007995.2013.810615, pages 1127 - 1135, XP055391171
OPPOSITION- Tschentke T. M. et al, "Tapentadol Hydrochloride", Drugs of the Future, (20060100), vol. 31, no. 12, pages 1053 - 1061, XP055365206

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents